000 01403 a2200397 4500
005 20250511202342.0
264 0 _c19920227
008 199202s 0 0 eng d
022 _a0022-1007
024 7 _a10.1084/jem.175.2.371
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aClayberger, C
245 0 0 _aInterleukin 3 is a growth factor for human follicular B cell lymphoma.
_h[electronic resource]
260 _bThe Journal of experimental medicine
_cFeb 1992
300 _a371-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aCell Division
650 0 4 _aFemale
650 0 4 _aFluorescent Antibody Technique
650 0 4 _aHumans
650 0 4 _aInterleukin-3
_xpharmacology
650 0 4 _aLymphocyte Activation
650 0 4 _aLymphoma, B-Cell
_xdrug therapy
650 0 4 _aLymphoma, Follicular
_xdrug therapy
650 0 4 _aReceptors, Interleukin-3
_xmetabolism
650 0 4 _aRecombinant Proteins
_xpharmacology
650 0 4 _aTumor Cells, Cultured
700 1 _aLuna-Fineman, S
700 1 _aLee, J E
700 1 _aPillai, A
700 1 _aCampbell, M
700 1 _aLevy, R
700 1 _aKrensky, A M
773 0 _tThe Journal of experimental medicine
_gvol. 175
_gno. 2
_gp. 371-6
856 4 0 _uhttps://doi.org/10.1084/jem.175.2.371
_zAvailable from publisher's website
999 _c1738808
_d1738808